Two Sigma Securities’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.5K Buy
+15,641
New +$31.9K ﹤0.01% 1440
2025
Q3
Sell
-12,821
Closed -$31K 1687
2025
Q2
$31K Buy
+12,821
New +$17.4K ﹤0.01% 1149
2024
Q1
Sell
-11,073
Closed -$21K 3257
2023
Q4
$21K Buy
+11,073
New +$16.5K ﹤0.01% 2716

Other funds holding NBP

Two Sigma Securities's NBP Position: Q2 2026 in Review

Two Sigma Securities opened a new position in NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2026: 15,641 shares worth $30.5K. The stake represents ﹤0.01% of the portfolio and ranks #1440 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in NBP as recently as Q2 2025.

Two Sigma Securities first reported a position in NBP in Q4 2023 and has held it in 3 quarters since. The position peaked at $31K in Q2 2025. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • Two Sigma Securities held 15,641 shares of NovaBridge Biosciences American Depositary Shares worth $30.5K as of Q2 2026.
  • NovaBridge Biosciences American Depositary Shares was a new Two Sigma Securities position in Q2 2026.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1440 holding.
  • Two Sigma Securities first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2023 and has held it in 3 quarters since.
  • Two Sigma Securities's NovaBridge Biosciences American Depositary Shares position peaked at $31K in Q2 2025.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.